⌘K

Home/Filings/4/0001209191-16-149847

4//SEC Filing

OBALON THERAPEUTICS INC 4

Accession 0001209191-16-149847

$HINDCIK 0001427570operating

View on SEC.gov Company Profile

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 5:49 PM ET

Size

5.5 KB

Accession

0001209191-16-149847

Insider Transaction Report

Form 4

Period: 2016-11-09

OBALON THERAPEUTICS INCOBLN

VP of Research and Development

Transactions

Award
Stock Option (right to buy)
2016-11-09+90,000→ 90,000 total
Exercise: $8.74Exp: 2026-11-09→ Common Stock (90,000 underlying)

Footnotes (1)

[F1]The option vests as to 2.0833% of the total shares monthly, commencing on December 9, 2016, with 100% of the total shares vested on November 9, 2020, subject to the reporting person's provision of service to the issuer on each vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

OBALON THERAPEUTICS INC

CIK 0001427570

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001427570

Filing Metadata

Form type: 4
Filed: Nov 13, 7:00 PM ET
Accepted: Nov 14, 5:49 PM ET
Size: 5.5 KB

View on SEC.gov